Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04826887 · ClinicalTrials.gov registry record
SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia
A clinical trial, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- 15
- Enrollment target
NCT04826887 is a clinical trial that has completed, run by University of Kansas Medical Center. The registered enrollment target is 15 participants.
The verdict
NCT04826887 has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
To compare intraoperative as well as postoperative outcomes of SOLTIVE Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP) vs Holmium Laser Enucleation of the Prostate. Our hypothesis is that utilizing the SOLTIVE Thulium laser enucleation of the prostate will result in a more efficient procedure, comparable results to that of Holmium laser enucleation of the prostate and subjective improvement of prior device limitations
Interventions
- OTHER SOLTIVE Thulium Laser
- OTHER Standard of Care (Holmium Laser)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-04-14 |
| Est. Completion | 2024-05-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04826887
The ClinicalTrials.gov registry entry for NCT04826887 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SOLTIVE Thulium Laser is the first listed.
NCT04826887 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04826887 about?
NCT04826887 is a clinical study titled "SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia". To compare intraoperative as well as postoperative outcomes of SOLTIVE Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP) vs Holmium Laser Enucleation of the Prostate. Our hypothesis is that utilizing the SOLTIVE Thulium laser enucleation of the prostate will result in a more efficient proce...
What is the current status of trial NCT04826887?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2021-04-14. Estimated completion is 2024-05-02.
What interventions are being tested in trial NCT04826887?
The interventions under investigation include: SOLTIVE Thulium Laser (OTHER), Standard of Care (Holmium Laser) (OTHER).
Who is sponsoring clinical trial NCT04826887?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.